The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4+CD25+ regulatory T cells

Rheumatology International

Volumn 33, Issue 2, 2013, Pages 381-388

  Oh, Ji Seon ^a   Kim, Yong Gil ^a   Lee, Seung Geun ^b   So, Min Wook ^a   Choi, Seung Won ^a   Lee, Chang Keun ^a   Yoo, Bin ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Antirheumatic agents; Infliximab; Leflunomide; Methotrexate; Regulatory T lymphocytes; Rheumatoid arthritis; Sulfasalazine

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; DRUG EFFECT; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIRHEUMATIC AGENTS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; ISOXAZOLES; LYMPHOCYTE ACTIVATION; METHOTREXATE; RNA, MESSENGER; SULFASALAZINE; T-LYMPHOCYTES, REGULATORY;

EID: 84873990672     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2365-9     Document Type: Article

References (49)

1. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S (1999) Thymus and autoimmunity: production of CD25+ CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317-5326
2. Taams LS, Akbar AN (2005) Peripheral generation and function of CD4+ CD25+ regulatory T cells. Curr Top Microbiol Immunol 293:115-131
3. Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC, Akbar AN, Bijlsma JW, Lafeber FP (2005) Modulation of monocyte/macrophage function by human CD4+ CD25+ regulatory T cells. Hum Immunol 66(3):222-230. doi: 10.1016/j.humimm.2004.12.006
4. Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV (2004) Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 172(8):4676-4680
5. Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30(5):636-645. doi: 10.1016/j.immuni.2009.04.010
6. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21(2):267-277. doi: 10.1016/j.immuni.2004.07.009
7. Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562. doi: 10.1146/annurev.immunol.21.120601.141122
8. Thornton AM, Shevach EM (1998) CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188(2):287-296
9. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20-21. doi: 10.1038/83713
10. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4(4):330-336. doi: 10.1038/ni904
11. Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+ CD25+ T regulatory cells. Nat Immunol 4(4):337-342. doi: 10.1038/ni909
12. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, Ziegler SF, Roncarolo MG, Levings MK (2005) The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115(11):3276-3284. doi: 10.1172/JCI24685
13. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+ CD25- T cells. J Clin Invest 112(9):1437-1443. doi: 10.1172/JCI19441
14. Pillai V, Ortega SB, Wang CK, Karandikar NJ (2007) Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 123(1):18-29. doi: 10.1016/j.clim.2006.10.014
15. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701-1711. doi: 10.1084/jem.20060772
16. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, Solomon M, Selby W, Alexander SI, Nanan R, Kelleher A, Fazekas de St Groth B (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203(7):1693-1700. doi: 10.1084/jem.20060468
17. Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R (2005) The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+ CD25+ T cells. Arthritis Res Ther 7(2):R291-R301. doi: 10.1186/ar1484
18. Lawson CA, Brown AK, Bejarano V, Douglas SH, Burgoyne CH, Greenstein AS, Boylston AW, Emery P, Ponchel F, Isaacs JD (2006) Early rheumatoid arthritis is associated with a deficit in the CD4+ CD25 high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 45(10):1210-1217. doi: 10.1093/rheumatology/kel089
19. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200(3):277-285. doi: 10.1084/jem.20040165
20. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood 108(1):253-261. doi: 10.1182/blood-2005-11-4567
21. Porter SB, Liu B, Rogosheske J, Levine BL, June CH, Kohl VK, Wagner JE, Miller JS, Blazar BR (2006) Suppressor function of umbilical cord blood-derived CD4+ CD25+ T-regulatory cells exposed to graft-versus-host disease drugs. Transplantation 82(1):23-29. doi: 10.1097/01.tp.0000225824.48931.af
22. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS (2004) CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthr Rheum 50(9):2775-2785. doi: 10.1002/art.20499
23. Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmstrom V (2004) CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthr Res Ther 6(4):R335-R346. doi: 10.1186/ar1192
24. Liu MF, Wang CR, Fung LL, Lin LH, Tsai CN (2005) The presence of cytokine-suppressive CD4+ CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 62(3):312-317. doi: 10.1111/j.1365-3083.2005.01656.x
25. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH (2001) Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 60(8):729-735
26. Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376(9746):1094-1108. doi: 10.1016/S0140-6736(10)60826-4
27. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS (2003) Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21(5 suppl 31):S179-S185
28. Fox RI (1998) Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumatol Suppl 53:20-26
29. Cao WW, Kao PN, Aoki Y, Xu JC, Shorthouse RA, Morris RE (1996) A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2. Transp Proc 28(6):3079-3080
30. Barrera P, Haagsma CJ, Boerbooms AM, Van Riel PL, Borm GF, Van de Putte LB, Van der Meer JW (1995) Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br J Rheumatol 34(8):747-755
31. Imai F, Suzuki T, Ishibashi T, Dohi Y (1991) Effect of sulfasalazine on B cells. Clin Exp Rheumatol 9(3):259-264
32. Fujiwara M, Mitsui K, Yamamoto I (1990) Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites. Jpn J Pharmacol 54(2):121-131
33. Shen C, Van Assche G, Rutgeerts P, Ceuppens JL (2006) Caspase activation and apoptosis induction by adalimumab: demonstration in vitro and in vivo in a chimeric mouse model. Inflamm Bowel Dis 12(1):22-28. doi: 10.1097/01.MIB. 0000194185.69800.07
34. Shen C, Assche GV, Colpaert S, Maerten P, Geboes K, Rutgeerts P, Ceuppens JL (2005) Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Aliment Pharmacol Ther 21(3):251-258. doi: 10.1111/j.1365-2036.2005.02309.x
35. Nesbitt A, Fossati G, Bergin M, Stephens P, Stephens S, Foulkes R, Brown D, Robinson M, Bourne T (2007) Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. Inflamm Bowel Dis 13(11):1323-1332. doi: 10.1002/ibd.20225
36. Suarez A, Lopez P, Gomez J, Gutierrez C (2006) Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 65(11):1512-1517. doi: 10.1136/ard.2005. 049924
37. Xu L, Xu Z, Xu M (2009) Glucocorticoid treatment restores the impaired suppressive function of regulatory T cells in patients with relapsing-remitting multiple sclerosis. Clin Exp Immunol 158(1):26-30. doi: 10.1111/j.1365-2249. 2009.03987.x
38. Banica L, Besliu A, Pistol G, Stavaru C, Ionescu R, Forsea AM, Tanaseanu C, Dumitrache S, Otelea D, Tamsulea I, Tanaseanu S, Chitonu C, Paraschiv S, Balteanu M, Stefanescu M, Matache C (2009) Quantification and molecular characterization of regulatory T cells in connective tissue diseases. Autoimmunity 42(1):41-49. doi: 10.1080/08916930802282651
39. Sbiera S, Dexneit T, Reichardt SD, Michel KD, van den Brandt J, Schmull S, Kraus L, Beyer M, Mlynski R, Wortmann S, Allolio B, Reichardt HM, Fassnacht M (2011) Influence of short-term glucocorticoid therapy on regulatory T cells in vivo. PLoS ONE 6(9):e24345. doi: 10.1371/journal.pone.0024345
40. Baan CC, van der Mast BJ, Klepper M, Mol WM, Peeters AM, Korevaar SS, Balk AH, Weimar W (2005) Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells. Transplantation 80(1):110-117. doi: 10.1097/01.TP.0000164142.98167.4B
41. Zeiser R, Nguyen VH, Beilhack A, Buess M, Schulz S, Baker J, Contag CH, Negrin RS (2006) Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108(1):390-399. doi: 10.1182/blood-2006-01-0329
42. Segundo DS, Ruiz JC, Izquierdo M, Fernandez-Fresnedo G, Gomez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, Lopez-Hoyos M, Arias M (2006) Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+ CD25+ FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82(4):550-557. doi: 10.1097/01.tp.0000229473.95202.50
43. Chu Z, Zhang J, Zhao Y, Ji Q, Zhong J, Zhang C, Zhang B (2010) Influence of immunosuppressive drugs on the development of CD4(+)CD25(high) Foxp3(+) T cells in liver transplant recipients. Transp Proc 42(7):2599-2601. doi: 10.1016/j.transproceed.2010.04.026
44. Chakraborty TK, Bhatia D, Heading RC, Ford MJ (1987) Salicylate induced exacerbation of ulcerative colitis. Gut 28(5):613-615
45. Schwartz AG, Targan SR, Saxon A, Weinstein WM (1982) Sulfasalazine- induced exacerbation of ulcerative colitis. N Engl J Med 306(7):409-412. doi: 10.1056/NEJM198202183060708
46. Wang TY, Li J, Li CY, Jin Y, Lu XW, Wang XH, Zhou Q (2010) Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+ CD25+ regulatory T cells. Can J Physiol Pharmacol 88(1):45-53. doi: 10.1139/Y09-094
47. Jin D, Duan K, Zhang L, Peng J, Zhao Y (2011) The effects of leflunomide on CD4(+)CD25 (+)Foxp3 (+) T regulatory cells in mice receiving allogeneic bone marrow transplantation. Inflamm Res Off J Euro Histamine Res Soc (et al.). doi: 10.1007/s00011-011-0388-4
48. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S (1998) Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10(12):1969-1980
49. Michel L, Berthelot L, Pettre S, Wiertlewski S, Lefrere F, Braudeau C, Brouard S, Soulillou JP, Laplaud DA (2008) Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J Clin Invest 118(10):3411-3419. doi: 10.1172/JCI35365